mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |